Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities

Ads

You May Also Like

World Concern President Calls for Action in Rohingya Refugee Crisis

SEATTLE, Wash., Feb. 06, 2018 (GLOBE NEWSWIRE) -- World Concern President Jacinta Tegman just ...

Tempus to Participate in the NCI-MATCH Clinical Trial

Having met rigorous qualifications, Tempus joins a select group of commercial and academic laboratories ...

Oncobiologics Announces Term Extension of Series A Warrants

CRANBURY, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (NASDAQ:ONSIW) (NASDAQ:ONSIZ) announced ...